Anti-Inflammatory Compounds, Pharmaceutical Compositions, and Methods of Treating Hemochromatosis, and Other Disorders
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,760,039 | Anti-Inflammatory Compounds, Pharmaceutical Compositions, and Methods of Treating Hemochromatosis, and Other Disorders In force · Medium confidence | Miralogx LLC | In force | Medium confidence | ||
| Application 19/416,585 | Zinc Co-Therapies for Treating Autoimmune Disorders, Bacterial Infections and Viral Infections Pending Not granted | Miralogx LLC | Pending | Not granted | ||
| Application 19/648,753 | Anti-Inflammatory Compounds, Pharmaceutical Compositions, and Methods of Treating Hemochromatosis and Other Disorders Pending Not granted | Miralogx LLC | Pending | Not granted | ||
| Application 19/650,023 | Anti-Inflammatory Compounds, Pharmaceutical Compositions, and Methods of Treating Hemochromatosis and Other Disorders Pending Not granted | Miralogx LLC | Pending | Not granted |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Miralogx LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.